• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.

作者信息

Webster D P, Gaulton T, Woodford N, Pike R, Turton J, Perry C, Bowler I C J W

出版信息

Int J Antimicrob Agents. 2010 Dec;36(6):575-6. doi: 10.1016/j.ijantimicag.2010.08.003. Epub 2010 Sep 24.

DOI:10.1016/j.ijantimicag.2010.08.003
PMID:20869852
Abstract
摘要

相似文献

1
Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.在美罗培南治疗期间，产超广谱β-内酰胺酶（ESBL）的肺炎克雷伯菌菌株因孔蛋白缺失而出现碳青霉烯类耐药。
Int J Antimicrob Agents. 2010 Dec;36(6):575-6. doi: 10.1016/j.ijantimicag.2010.08.003. Epub 2010 Sep 24.
2
In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment.在美罗培南治疗过程中 OmpK36 丢失导致耐碳青霉烯类肺炎克雷伯菌的体内选择。
Diagn Microbiol Infect Dis. 2009 Dec;65(4):447-9. doi: 10.1016/j.diagmicrobio.2009.08.010. Epub 2009 Sep 18.
3
Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.马来西亚肺炎克雷伯菌和大肠杆菌中SHV-12的出现及OmpK35的缺失导致对超广谱β-内酰胺类药物产生耐药性。
J Microbiol Immunol Infect. 2009 Apr;42(2):129-33.
4
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.头孢吡肟和碳青霉烯类药物对产FOX-5β-内酰胺酶的孔蛋白缺陷型肺炎克雷伯菌所致实验性肺炎的活性。
Clin Microbiol Infect. 2005 Jan;11(1):31-8. doi: 10.1111/j.1469-0691.2004.01018.x.
5
Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.产超广谱β-内酰胺酶肺炎克雷伯菌和大肠埃希菌对亚胺培南或美罗培南耐药的流行率及其影响因素。
Diagn Microbiol Infect Dis. 2011 Sep;71(1):87-9. doi: 10.1016/j.diagmicrobio.2010.12.012. Epub 2011 Mar 11.
6
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.孔蛋白和质粒介导的AmpCβ-内酰胺酶对肺炎克雷伯菌所致大鼠肺炎中β-内酰胺类药物疗效的影响。
Antimicrob Agents Chemother. 2006 Jun;50(6):2258-60. doi: 10.1128/AAC.01513-05.
7
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.产超广谱β-内酰胺酶大肠埃希菌或肺炎克雷伯菌菌血症的碳青霉烯类治疗。
Diagn Microbiol Infect Dis. 2011 May;70(1):150-3. doi: 10.1016/j.diagmicrobio.2010.12.008. Epub 2011 Mar 12.
8
Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase.内镜检查相关的产KPC-2β-内酰胺酶的耐碳青霉烯类肺炎克雷伯菌的传播
J Antimicrob Chemother. 2010 Jun;65(6):1305-6. doi: 10.1093/jac/dkq117. Epub 2010 Apr 9.
9
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.以色列一家医院耐碳青霉烯类肺炎克雷伯菌菌株中KPC-2和KPC-3的出现。
Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9. doi: 10.1128/AAC.00299-07. Epub 2007 Jun 11.
10
Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.韩国碳青霉烯类耐药肠杆菌科分离株的特征。
Diagn Microbiol Infect Dis. 2013 Aug;76(4):486-90. doi: 10.1016/j.diagmicrobio.2013.04.006. Epub 2013 May 18.

引用本文的文献

1
Mechanisms of Antimicrobial Resistance in : Advances in Detection Methods and Clinical Implications.《抗菌药物耐药机制：检测方法进展与临床意义》
Infect Drug Resist. 2025 Mar 11;18:1339-1354. doi: 10.2147/IDR.S509016. eCollection 2025.
2
Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing .孔蛋白缺失对多黏菌素与β-内酰胺/β-内酰胺酶抑制剂联合应用对产 ESBL 和碳青霉烯酶. 的协同作用的影响。
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0076224. doi: 10.1128/aac.00762-24. Epub 2024 Oct 4.
3
Mutations in differentially impact synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing .
中的突变对美罗培南/巴硼巴坦以及头孢他啶/阿维巴坦与其他抗生素联合使用针对产KPC的协同作用有不同影响。
JAC Antimicrob Resist. 2023 Oct 26;5(5):dlad113. doi: 10.1093/jacamr/dlad113. eCollection 2023 Oct.
4
Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.外膜和孔蛋白在产β-内酰胺酶肠杆菌科细菌对头孢他啶-阿维巴坦敏感性中的作用
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1349-59. doi: 10.1128/AAC.01585-15.
5
Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan.台湾地区肺炎克雷伯菌菌株中的黏菌素耐药机制
Antimicrob Agents Chemother. 2015 May;59(5):2909-13. doi: 10.1128/AAC.04763-14. Epub 2015 Feb 17.
6
Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania.坦桑尼亚姆万扎一家三级医院耐多药革兰氏阴性临床分离株中的碳青霉烯酶基因。
Biomed Res Int. 2014;2014:303104. doi: 10.1155/2014/303104. Epub 2014 Feb 24.
7
Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.产 CTX-M-15 厄他培南耐药肺炎克雷伯菌 101 型携带 OmpK36 孔蛋白变异体克隆引起的暴发。
J Clin Microbiol. 2013 Oct;51(10):3176-82. doi: 10.1128/JCM.01244-13. Epub 2013 Jul 12.
8
Carbapenems: past, present, and future.碳青霉烯类抗生素：过去、现在和未来。
Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60. doi: 10.1128/AAC.00296-11. Epub 2011 Aug 22.